Ownership history in COMMONWEALTH EQUITY SERVICES, LLC · 6 quarters on record
This page tracks every 13F SEC filing in which COMMONWEALTH EQUITY SERVICES, LLC reported a position in NEUROSENSE THERAPEUTICS LTD (NRSN). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 22,775 | +1,695 | +8.0% | 0.00% | $18K | $0.77 |
| 2025 Q3 | UNCHANGED | 21,080 | — | 0% | 0.00% | $26K | $1.25 |
| 2025 Q2 | ADDED | 21,080 | +3,830 | +22.2% | 0.00% | $40K | $1.89 |
| 2025 Q1 | ADDED | 17,250 | +1,000 | +6.2% | 0.00% | $16K | $0.93 |
| 2024 Q4 | ADDED | 16,250 | +3,625 | +28.7% | 0.00% | $20K | $1.20 |
| 2024 Q3 | INITIATED | 12,625 | — | — | 0.00% | $16K | $1.27 |
As of 2025 Q4 — sorted by position size